| scholarly article | Q13442814 |
| P356 | DOI | 10.1021/JM0256169 |
| P953 | full work available at URL | https://pubs.acs.org/doi/pdf/10.1021/jm0256169 |
| P698 | PubMed publication ID | 12747775 |
| P2093 | author name string | Richard M. Schultz | |
| Chuan Shih | |||
| Guoxin Zhu | |||
| Xun Zhou | |||
| Beverly Teicher | |||
| Bharvin Patel | |||
| Cathy Ogg | |||
| Eileen Considine | |||
| Margaret M. Faul | |||
| Robert Morris Campbell | |||
| Tiechao Li | |||
| Bryan D. Anderson | |||
| Charles D. Spencer | |||
| Harold B. Brooks | |||
| Jack A. Dempsey | |||
| Scott A. Watkins | |||
| Scott E. Conner | |||
| P2860 | cites work | Cancer Research | Q326097 |
| Biochemical and Biophysical Research Communications | Q864228 | ||
| Journal of Biological Chemistry | Q867727 | ||
| Nature Cell Biology | Q1574111 | ||
| Bioorganic & Medicinal Chemistry Letters | Q2709483 | ||
| Journal of Organic Chemistry | Q898967 | ||
| Journal of Medicinal Chemistry | Q900316 | ||
| Tetrahedron Letters | Q903432 | ||
| Experimental Cell Research | Q1524289 | ||
| Cancer surveys | Q27710283 | ||
| A cell cycle regulator potentially involved in genesis of many tumor types | Q28251933 | ||
| Cell cycle checkpoints: preventing an identity crisis | Q29547644 | ||
| Cyclin-dependent kinases: engines, clocks, and microprocessors | Q29614786 | ||
| Cell cycle control and cancer | Q29617536 | ||
| Four-dimensional control of the cell cycle | Q33772655 | ||
| Pharmacological inhibitors of cyclin-dependent kinases | Q34866778 | ||
| Inhibition of cyclin-dependent kinase 2 by p21 is necessary for retinoblastoma protein-mediated G1 arrest after gamma-irradiation | Q34946238 | ||
| Regulation of transcription by proteins that control the cell cycle | Q40882566 | ||
| Purification, characterization, and kinetic mechanism of cyclin D1. CDK4, a major target for cell cycle regulation | Q41005486 | ||
| Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms. | Q52184569 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | molecular medicine | Q3523816 |
| proto-oncogene protein | Q66020913 | ||
| P304 | page(s) | 2027-2030 | |
| P577 | publication date | 2003-05-01 | |
| 2003-05-22 | |||
| P1433 | published in | Journal of Medicinal Chemistry | Q900316 |
| P1476 | title | Synthesis, structure-activity relationship, and biological studies of indolocarbazoles as potent cyclin D1-CDK4 inhibitors | |
| Synthesis, Structure−Activity Relationship, and Biological Studies of Indolocarbazoles as Potent Cyclin D1-CDK4 Inhibitors | |||
| P478 | volume | 46 |
| Q40627104 | Aryl[ a ]pyrrolo[3,4- c ]carbazoles as selective cyclin D1-CDK4 inhibitors |
| Q112977840 | CDK4 inhibitors bind CDK4 |
| Q46648732 | Cell-cycle regulators are involved in transient cerebral ischemia induced neuronal apoptosis in female rats |
| Q51919465 | Dentofacial parameters explaining variability in retroclination of the maxillary central incisors. |
| Q37697450 | Discovery of 8-cyclopentyl-2-[4-(4-methyl-piperazin-1-yl)-phenylamino]-7-oxo-7,8-dihydro-pyrido[2,3-d]pyrimidine-6-carbonitrile (7x) as a potent inhibitor of cyclin-dependent kinase 4 (CDK4) and AMPK-related kinase 5 (ARK5). |
| Q33686745 | Discovery of Phosphatidylinositol 3-Kinase Inhibitory Compounds from the Screening Committee of Anticancer Drugs (SCADS) Library |
| Q30505125 | Drug-induced cell cycle modulation leading to cell-cycle arrest, nuclear mis-segregation, or endoreplication |
| Q36376583 | Dual suppression of the cyclin-dependent kinase inhibitors CDKN2C and CDKN1A in human melanoma. |
| Q79079759 | Effective Strategy for the Preparation of Indolocarbazole Aglycons and Glycosides: Total Synthesis of Tjipanazoles B, D, E, and I |
| Q34487091 | Effects of an Indolocarbazole-Derived CDK4 Inhibitor on Breast Cancer Cells |
| Q36611467 | Expression of thymidylate synthase in human cells is an early G(1) event regulated by CDK4 and p16INK4A but not E2F. |
| Q90391581 | Halogenation-guided chemical screening provides insight into tjipanazole biosynthesis by the cyanobacterium Fischerella ambigua |
| Q40413322 | Latent membrane protein 1 encoded by Epstein-Barr virus modulates directly and synchronously cyclin D1 and p16 by newly forming a c-Jun/Jun B heterodimer in nasopharyngeal carcinoma cell line |
| Q45125293 | Loop flexibility and solvent dynamics as determinants for the selective inhibition of cyclin-dependent kinase 4: comparative molecular dynamics simulation studies of CDK2 and CDK4. |
| Q57409028 | Metabolic regulation of pluripotency and germ cell fate through α‐ketoglutarate |
| Q35709857 | Methanol extract of wheatgrass induces G1 cell cycle arrest in a p53-dependent manner and down regulates the expression of cyclin D1 in human laryngeal cancer cells-an in vitro and in silico approach |
| Q33968055 | Mitigation of hematologic radiation toxicity in mice through pharmacological quiescence induced by CDK4/6 inhibition. |
| Q73568106 | Novel, potent and selective cyclin D1/CDK4 inhibitors: indolo[6,7-a]pyrrolo[3,4-c]carbazoles |
| Q38196712 | Radioprotection of normal tissue cells |
| Q36120794 | Recent progress in the discovery and development of cyclin-dependent kinase inhibitors |
| Q54705317 | Simultaneous inhibition of MEK and CDK4 leads to potent apoptosis in human melanoma cells. |
| Q35551149 | Small-molecule cyclin-dependent kinase modulators |
| Q40627098 | Studies on cyclin-dependent kinase inhibitors: indolo-[2,3- a ]pyrrolo[3,4- c ]carbazoles versus bis-indolylmaleimides |
| Q39673439 | Synthesis of 3,3-diindolyl oxyindoles efficiently catalysed by FeCl3 and their in vitro evaluation for anticancer activity |
| Q92601553 | The Cervicovaginal Microbiota-Host Interaction Modulates Chlamydia trachomatis Infection |
| Q35840229 | The different roles of cyclinD1-CDK4 in STP and mGluR-LTD during the postnatal development in mice hippocampus area CA1. |
Search more.